HS-20094
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Regeneron · Phase 2 · Recruiting · Enrollment 360
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Olatorepatide arm 1 | n/r | n/r | n/r | n/r |
| Olatorepatide arm 2 | n/r | n/r | n/r | n/r |
| Olatorepatide arm 3 | n/r | n/r | n/r | n/r |
| Olatorepatide arm 4 | n/r | n/r | n/r | n/r |
| Olatorepatide arm 5 | n/r | n/r | n/r | n/r |
| Matching Placebo arm 6 | n/r | n/r | n/r | n/r |
Not shown
- Olatorepatide arm 1: endpoint not reported
- Olatorepatide arm 2: endpoint not reported
- Olatorepatide arm 3: endpoint not reported
- Olatorepatide arm 4: endpoint not reported
- Olatorepatide arm 5: endpoint not reported
- Matching Placebo arm 6: endpoint not reported